John C. Mathison

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Hybrid cells producing monoclonal anti-CD14 antibodies
- Patent number 7,326,569
- Issue date Feb 5, 2008
- The Scripps Research Institute
- Didier J. Leturcq
- G01 - MEASURING TESTING
Information Patent Grant
Methods and compositions for ameliorating the symptoms of sepsis
- Patent number 6,495,332
- Issue date Dec 17, 2002
- The Sripps Research Institute
- Richard Ulevitch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting CD14 mediated cell activation
- Patent number 6,444,206
- Issue date Sep 3, 2002
- The Scripps Research Institute
- Didier J. Leturcq
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for ameliorating the symptoms of sepsis
- Patent number 6,297,049
- Issue date Oct 2, 2001
- The Scripps Research Institute
- Richard Ulevitch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for ameliorating the symptoms of sepsis
- Patent number 6,045,795
- Issue date Apr 4, 2000
- The Scripps Research Institute
- Richard Ulevitch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting CD14 mediated cell activation
- Patent number 5,820,858
- Issue date Oct 13, 1998
- The Scripps Research Institute
- Didier J. Leturcq
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for ameliorating the symptoms of sepsis
- Patent number 5,730,980
- Issue date Mar 24, 1998
- The Scripps Research Institute
- Richard Ulevitch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Methods and compositions for inhibiting CD14 mediated cell activation
- Publication number 20060073145
- Publication date Apr 6, 2006
- THE SCRIPPS RESEARCH INSTITUTE
- Didier J. Leturcq
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods and compositions for ameliorating the symptoms of sepsis
- Publication number 20020034509
- Publication date Mar 21, 2002
- Richard Ulevitch
- C07 - ORGANIC CHEMISTRY

John C. Mathison

Person

Patents Grantslast 30 patents

Hybrid cells producing monoclonal anti-CD14 antibodies

Methods and compositions for ameliorating the symptoms of sepsis

Methods and compositions for inhibiting CD14 mediated cell activation

Methods and compositions for ameliorating the symptoms of sepsis

Methods and compositions for ameliorating the symptoms of sepsis

Methods and compositions for inhibiting CD14 mediated cell activation

Methods and compositions for ameliorating the symptoms of sepsis

Patents Applicationslast 30 patents

Methods and compositions for inhibiting CD14 mediated cell activation

Methods and compositions for ameliorating the symptoms of sepsis